HEBON Investigators

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes”.

Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

Nature Genetics(2020)10.1038/s41588-019-0537-1

N/A

0DataRank · unranked

189 citations

Laura Fachal, EMBRACE Collaborators, KConFab Investigators, HEBON Investigators, ABCTB Investigators +95 more

Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer

npj Breast Cancer(2020)10.1038/s41523-020-00185-6

N/A

0DataRank · unranked

10 citations

Sofia Khan, Rainer Fagerholm, Kristiina Aittomäki, Julie M. Cunningham, Joe Dennis +39 more

Breast and Prostate Cancer Risks for MaleBRCA1andBRCA2Pathogenic Variant Carriers Using Polygenic Risk Scores

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab147

N/A

0DataRank · unranked

44 citations

Valentina Silvestri, Goska Leslie, Lesley McGuffog, Joe Dennis, Xin Yang +95 more

Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers

Communications Biology(2022)10.1038/s42003-022-03978-6

N/A

0DataRank · unranked

15 citations

John F. Pearson, Louise Marquart, Joe Dennis, George A. R. Wiggins, Daniel R. Barnes +95 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5

N/A

0DataRank · unranked

19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

npj Breast Cancer(2023)10.1038/s41523-023-00546-x

N/A

0DataRank · unranked

7 citations

Anna Morra, Sofia Khan, Daniel R. Barnes, Manjeet K. Bolla, Joe Dennis +65 more